return to results page

VAERS ID: 1000382

AGE: UNK| SEX: M|State: FR

Description

Pulmonary embolism; shortness of breath; heaviness in calf; This is a spontaneous report received from a contactable healthcare professional by Pfizer from the United Kingdom's Medicines and Healthcare products Regulatory Agency (UK-MHRA). The regulatory authority report number is GB-MHRA-WEBCOVID-202101280910469380 and GB-MHRA-ADR 24658296. A 58-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EJ1688), via an unspecified route of administration, on 07Jan2021 at a single dose for COVID-19 immunization. Medical history included hypertension. The patient did not have any symptoms associated with COVID-19. The patient was not enrolled in clinical trial. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 17Dec2020 for COVID-19 immunization. The patient experienced shortness of breath and pulmonary embolism on 25Jan2021, both of which were reported with a seriousness criterion of hospitalization and life-threatening. The patient also experienced heaviness in calf in Jan2021. It was reported that 48 hours prior to becoming unwell, the patient had a heaviness in calf and on 25Jan2021, the patient complained of shortness of breath on exercise with low oxygen saturations. The patient underwent lab tests and procedures which included COVID-19 virus test: no - negative COVID-19 test on an unspecified date. The clinical outcome of heaviness in calf and shortness of breath was unknown and of pulmonary embolism was recovering. It was also reported that since the vaccination, the patient has not tested positive for COVID-19. No follow-up attempts possible. No further information is expected.

Symptoms

Dyspnoea, Limb discomfort, Oxygen saturation, Pulmonary embolism, SARS-CoV-2 test

Vaccines

VAX DATE: 06 January 2021 | ONSET DATE: 31 December 2020 | DAYS TO ONSET:
Vaccine TypeManufacturerVaccine NameDoseRouteSiteLot
  • COVID19
  • PFIZERBIONTECH
  • COVID19 (COVID19 (PFIZER-BIONTECH))
  • 2
  • EJ1688

RECVDATE:
03 February 2021
CAGE_YR:
CAGE_MO:
RPT_DATE:
DIED:
DATEDIED:
L_THREAT:
Y
ER_VISIT:
HOSPITAL:
Y
HOSPDAYS:
X_STAY:
DISABLE:
RECOVD:
N
LAB_DATA:
Test Date: 20210125; Test Name: oxygen saturations; Result Unstructured Data: Test Result:low; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative COVID-19 test
V_ADMINBY:
OTH
OTHER_MEDS:
CUR_ILL:
HISTORY:
Medical History/Concurrent Conditions: Hypertension; Comments: Hypertension nil else Patient has not had symptoms associated with COVID-19 Patient is not enrolled in clinical trial
PRIOR_VAX:
SPLTTYPE:
GBPFIZER INC2021090845
FORM_VERS:
2
TODAYS_DATE:
01 February 2021
BIRTH_DEFECT:
OFC_VISIT:
ER_ED_VISIT:
ALLERGIES:
V_FUNDBY:
return to results page

Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.

AND PLEASE read the FAQ first.

OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.